Prescribing information For Healthcare Professionals Only

Cilest®

35 / 250 micrograms
film-coated tablets

ACTIVE INGREDIENT(s): 0.035 mg ethinylestradiol and 0.25 mg norgestimate

Prescribing information

Concerta®

Prolonged Release Tablets

ACTIVE INGREDIENT(s): methylphenidate hydrochloride

Prescribing information

Daktacort®

2% / 1% w/w
Cream and Ointment

ACTIVE INGREDIENT(s): Miconazole nitrate 2% w/w and hydrocortisone 1% w/w

Prescribing information

Darzalex®

20 mg/ml concentrate
for solution for infusion

ACTIVE INGREDIENT(s): Daratumumab

Prescribing information

Durogesic® Dtrans®

12/25/50/75/100 mcg/hr
Transdermal Patch

ACTIVE INGREDIENT(s): fentanyl

Prescribing information

Edurant®

25 mg film-coated tablet

ACTIVE INGREDIENT(s): rilpivirine

Prescribing information

EVRA®

203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch

ACTIVE INGREDIENT(s): norelgestromin and ethinyl estradiol

Prescribing information

HALDOL®

2 mg/ml oral solution

ACTIVE INGREDIENT(s): Haloperidol

Prescribing information

HALDOL® decanoate

50 mg/ml and 100 mg/ml solution for injection

ACTIVE INGREDIENT(s): Haloperidol decanoate

Prescribing information

IMBRUVICA®

140mg Hard Capsules

ACTIVE INGREDIENT(s): ibrutinib

Prescribing information

INTELENCE®

25 mg, 100 mg & 200 mg tablets

ACTIVE INGREDIENT(s): etravirine

Prescribing information

INVEGA®

3mg, 6 mg and 9 mg prolonged release tablets

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

PREZISTA®

100mg/ml oral suspension and 75mg, 150mg, 400mg, 600mg and 800mg film-coated tablets

ACTIVE INGREDIENT(s): darunavir

Prescribing information

REZOLSTA®

800 mg/150 mg film-coated tablets

ACTIVE INGREDIENT(s): Darunavir and cobicistat

Prescribing information

RISPERDAL® CONSTA®

25mg, 37.5mg and 50mg injection

ACTIVE INGREDIENT(s): risperidone

Prescribing information

RISPERDAL® Film-Coated

Tablets, Oral Solution and Risperdal® Quicklet® Orodispersible Tablets

ACTIVE INGREDIENT(s): risperidone

Prescribing information

STELARA®

45 mg and 90 mg solution for injection and 130 mg concentrate for solution for infusion

ACTIVE INGREDIENT(s): ustekinumab

Prescribing information

SYMTUZA®

800 mg/150 mg/200 mg/10 mg film-coated tablets

ACTIVE INGREDIENT(s): darunavir, cobicistat, emtricitabine, tenofovir alafenamide

Prescribing information

Tremfya®

100 mg solution for injection

ACTIVE INGREDIENT(s): guselkumab

Prescribing information

TREVICTA®

175 mg, 263 mg, 350 mg & 525 mg prolonged release suspension for injection

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

VELCADE®

3.5 mg powder for solution for injection

ACTIVE INGREDIENT(s): bortezomib

Prescribing information

XEPLION®

50 mg, 75 mg, 100 mg & 150 mg prolonged release suspension for injection

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

ZYTIGA®

500 mg film-coated tablets

ACTIVE INGREDIENT(s): abiraterone acetate

Prescribing information
You are now leaving a Janssen website

This link will take you to a website where our Privacy Policy does not apply.

Click OK to continue.